[Short-term outcome of sacral neuromodulation on refractory interstitial cystitis/pelvic pain syndrome].
Zhonghua Yi Xue Za Zhi
; 96(48): 3875-3878, 2016 Dec 27.
Article
em Zh
| MEDLINE
| ID: mdl-28057156
ABSTRACT
Objective:
To summarize the initial experiences of applying sacral neuromodulation (SNM) for refractory interstitial cystitis/pelvic pain syndrome (IC/PPS).Methods:
From January 2013 to August 2016, 26 patients with refractory IC/PPS (including 5 males and 21 females) treated with SNM were recruited in Beijing Chaoyang Hospital and Hebei Yanda Hospital in this retrospective study. The data before operation, after implantation of stage â tined lead, and during short-term follow-up after implantation of stage â ¡ implanted pulse generator (IPG) were compared in order to observe the improvement of relevant symptoms, and to summarize the effectiveness and safety of SNM for IC/PPS.Results:
All the 26 patients received stage â tined lead implantation under local anesthesia, of whom 7 patients finally had the tined lead removed under local anesthesia because of poor testing effects. And 19 patients chose embedding of IPG at the end of stageâ , with the conversion rate from stage â to stage â ¡ being 73.1%. The mean follow-up time after stage â ¡ was 12.1 months. The data at the end of follow-up compared with those before treatment were voiding frequency in 24 hours 24.3±9.6 vs 13.5±5.7, nocturia 4.6±2.2 vs 2.7±1.5, average voiding amount (109.4 ±45.3)vs(172.6±61.6) ml, O'leary-sant scale score 26.0±3.1 vs 17.0±3.8, quality of life (QOL) score 5.7±0.4 vs 3.3±1.3, sex rating 5.4±1.4 vs 2.9±1.6, and Numeric Pain Intensity Scale 8.4±1.7 vs 3.9±1.2 (all P<0.05). During the follow-up period for the 19 patients, 11 showed symptoms relieve without recurrence, 5 patients had slightly symptoms recurrence and 3 patients had severe recurrence of pelvic pain and frequent urination. About 42.1%(8/19) patients received reprogramming, the average reprogramming rate being 1.73/person. And 84.2% (16/19) patients had symptoms improvement greater than 50% after stage â ¡ IPG implantation.Conclusions:
SNM is an effective, safe and minimally invasive procedure for refractory IC/PPS. IC/PPS is a good indication for SNM with a high conversion rate from stage â to stage â ¡. Patients should be followed up regularly after operation, and reprogramming should be arranged according to the degree of symptom improvement.
Texto completo:
1
Coleções:
01-internacional
Base de dados:
MEDLINE
Assunto principal:
Qualidade de Vida
/
Terapia por Estimulação Elétrica
/
Dor Pélvica
/
Cistite Intersticial
/
Eletrodos Implantados
Tipo de estudo:
Observational_studies
Limite:
Female
/
Humans
/
Male
Idioma:
Zh
Revista:
Zhonghua Yi Xue Za Zhi
Ano de publicação:
2016
Tipo de documento:
Article
País de afiliação:
China